Andrew Taylor named as new EVP of Food & Beverage Biosolutions

COPENHAGEN, Denmark – April 28, 2025. Andrew Taylor has been named Executive Vice President of Food & Beverage Biosolutions. He will join Novonesis in the second half of 2025, no later than September 1. 

Ester Baiget, CEO of Novonesis, welcomes our future colleague:

“I’m excited to welcome Andrew Taylor to Novonesis. Andrew brings a unique expert profile to Novonesis: deep understanding of the food ingredients industry, profound commercial acumen, and a superior track record of driving transformational change and growth. Furthermore, his vast international experience, analytical mindset, and – perhaps most importantly - his passion for biosolutions makes him a perfect fit for Novonesis.”

Throughout his career, Andrew has demonstrated vast experience within international, strategic leadership. Andrew joined Tate & Lyle in 2017, where he led Innovation & Commercial Development and the global stevia business, as well as the P&L for all Tate & Lyle’s Growth markets since 2020. Most recently he held the position as the company’s Chief Commercial and Chief Transformation Officer, being responsible for the transformation of the organization, key accounts, as well as driving Tate & Lyle’s acquisition and integration of global ingredient producer CP Kelco.

Prior to joining Tate & Lyle, Andrew spent close to 20 years at Boston Consulting Group as Senior Partner and Managing Director, where he focused on food, food ingredients and innovation across markets. His expertise included wide aspects such as Strategy Development, Innovation & Product transformation, Operational Improvement, M&A and Business Development. Andrew has spent a great deal of his personal and professional life living in the U.S, Asia, Latin America and Middle East.

Andrew Taylor shares his thoughts on joining the leadership team:

“I am truly excited to join the company at such an interesting time in the company’s history and growth journey. With its unique technology and innovation platform, and unmatched enzymatic and culture portfolio, Novonesis has an extraordinary position. From my background in the food ingredients sector, I’ve experienced first-hand the depth of Novonesis’ biosolutions portfolio, customer understanding and commercial capabilities. I look forward to getting to know my new colleagues, sharing our joint passion for developing innovative solutions and creating sustainable value for customers and society at large. The food and beverage sector holds much growth potential, and I’m excited to help grow the business even further, together with the Executive Leadership team and the rest of Novonesis.”